STOP Nitazenes Act
Sponsor

Full profile: /officials/L000566
Source: Congress.gov · FEC
Cosponsors (7)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-03-18
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2026-03-18
- House Committee on the JudiciaryReferred To · 2026-03-18
Previously
- Judiciary CommitteeReferred To · 2026-03-18
- Energy and Commerce CommitteeReferred To · 2026-03-18
Plain-English Summary
This bill would make nitazenes, a class of powerful synthetic opioids, illegal drugs under federal law and subject to criminal penalties similar to those for other dangerous controlled substances. Nitazenes are increasingly appearing on the street drug market and have been linked to overdose deaths, so the legislation aims to give law enforcement tools to prosecute their manufacture, distribution, and possession. The bill would affect drug traffickers, manufacturers, and potentially users caught with these substances.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7970 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7970 To amend the Controlled Substances Act to permanently schedule 2- benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 18, 2026 Mr. Latta introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Controlled Substances Act to permanently schedule 2- benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Strengthening Tools to Outlaw Poisonous Nitazenes Act'' or the ``STOP Nitazenes Act''. SEC. 2. CLASS I SCHEDULING OF NITAZENES. (a) In General.--Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of Schedule I the following: ``(f)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation that contains-- ``(A) any quantity of a 2-benzylbenzimidazole opioid; or ``(B) the salts, isomers, and salts of isomers of a 2- benzylbenzimidazole opioid. ``(2) For purposes of paragraph (1), the term `2- benzylbenzimidazole opioid' includes the following: ``(A) A substance that is structurally related to 2- benzylbenzimidazole with the following modifications: ``(i) At the 1-position, substitution with an alkyl linker connected to a substituted amine group containing hydrogen, alkyl, alkenyl, or a heteroaryl group, such as a morphilino, pyrrolidino, or piperidinyl group, whether or not further substituted. ``(ii) At the 2-position-- ``(I) replacement of the alkyl portion of the benzyl group with a substituted or unsubstituted alkyl, alkoxy, carbamates group, nitrogen, sulfur, or oxygen atom; or ``(II) replacement of the phenyl portion of the benzyl group with an aryl or heteroaryl group. ``(iii) Substitution on the phenyl portion of the benzimidazole ring with a hydrogen atom, halogen, nitro, cyano, substituted or unsubstituted amide, amine, alkyl, alkoxy, aryl, or heteroaryl group. ``(iv) At the 6-position, substitution with hydrogen, nitro, trifluoromethyl, methoxy, trifluoromethoxy, cyano, and halogen group. ``(B) A substance that exhibits agonist activity at the mu- opioid receptor. ``(C) Etonitazene, clonitazene, metonitazene, isotonitazene, protonitazene, butonitazene, etodesnitazene, flunitazene, N-pyrrolidino etonitazene, N-desethyl isotonitazene, and N-piperidinyl etonitazene. ``(3) The Attorney General may by order publish in the Federal Register a list of substances that satisfy the definition of the term `2-benzyl benzimidazole opioid' in paragraph (2).''. (b) Removal of Temporary Status.--Any substance included in the amendment made by subsection (a) that was temporarily scheduled under section 201(h) of the Controlled Substances Act (21 U.S.C. 811(h)) shall be deemed permanently scheduled and subject to the requirements of Schedule I of section 202(c) of that Act (21 U.S.C. 812(c)) as of the date of enactment of this Act. SEC. 3. RULEMAKING. (a) Interim Final Rule.--The Attorney General-- (1) shall, not later than 1 year after the date of enactment of this Act, issue rules to implement this Act, including the amendments made by this Act; and (2) may issue the rules under paragraph (1) as an interim final rule. (b) Procedure for Final Rule.-- (1) Effectiveness of interim final rules.--A rule issued by the Attorney General as an interim final rule under subsection (a) shall become immediately…
Show the remaining 95 wordsHide the remaining 95 words
effective as an interim final rule without requiring the Attorney General to demonstrate good cause therefor, notwithstanding subparagraph (B) of section 553(b) of title 5, United States Code. (2) Opportunity for comment and hearing.--An interim final rule issued under subsection (a) shall give interested persons the opportunity to comment and to request a hearing. (3) Final rule.--After the conclusion of proceedings under paragraph (2), the Attorney General shall issue a final rule to implement this Act, including the amendments made by this Act, in accordance with section 553 of title 5, United States Code. <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR7257SECURE Grid ActReferred to Committee · 2026-05-11
- HR7390SELF DRIVE Act of 2026Referred to Committee · 2026-02-10
- HR3638Electric Supply Chain ActPassed House · 2025-12-15
- HR6577Stop Penalizing Working Seniors ActReferred to Committee · 2025-12-10